文献速递免疫规划传染病防控与疫情报告

韩国武装部队中单剂四价脑膜炎球菌结合疫苗MenACWY-CRM的效果评价

Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces.
PubMed 文献 · Vaccine · 2019-11-29

该研究评估了韩国武装部队自2013年起实施的单剂四价脑膜炎球菌结合疫苗接种规划的效果。实施后脑膜炎球菌病发病率从0.52/10万降至0.06/10万,死亡数从4例降至0例;新兵中单剂结合疫苗的发病率为0.88(观察期19-23个月)。结果表明单剂四价结合疫苗可在高危人群中预防脑膜炎球菌感染,但需持续监测血清群变化。

要点

  • 实施疫苗接种规划后,脑膜炎球菌病发病率从0.52/10万降至0.06/10万。
  • 同期死亡数从4例降至0例。
  • 新兵中单剂结合疫苗的发病率为0.88(观察期19-23个月)。

核心结论

  • 单剂四价脑膜炎球菌结合疫苗接种可在士兵、旅行者和宿舍学生等高危人群中预防脑膜炎球菌感染。
  • 需要持续调查以确定血清群变化,包括B血清群。

研究设计与样本

  • 研究评估了韩国武装部队自2013年起实施的脑膜炎球菌疫苗接种规划的效果。
  • 原文未报告具体样本量。

主要发现

  • 实施疫苗接种规划后,脑膜炎球菌病发病率从0.52/10万降至0.06/10万。
  • 死亡数从4例降至0例。
  • 实施后发生的2例脑膜炎球菌病例鉴定为B血清群和X血清群。
  • 新兵中单剂结合疫苗接种的发病率为0.88(观察期19-23个月)。

临床怎么用

  • 作者认为单剂四价结合疫苗可在士兵、旅行者和宿舍学生等高危人群中预防脑膜炎球菌感染。
  • 作者指出需要持续调查以确定血清群变化,包括B血清群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Conjugate vaccines are widely used to overcome the disadvantages of polysaccharide vaccines in the prevention of meningococcal disease. However, limited studies have examined the clinical effectiveness of single-dose meningococcal quadrivalent conjugate vaccines in adults. We assessed the effectiveness of the meningococcal vaccination program in the Republic of Korea Armed Forces, since 2013. Following vaccination program implementation, meningococcal disease cases decreased from 0.52/100,000 to 0.06/100,000 and the number of deaths declined from four to zero. Two meningococcal cases that developed post-implementation were identified as serotype B and X. The effectiveness of single-dose conjugate vaccination in recruits, expressed as the incidence rate ratio, was 0.88 during a 19-23-month observation period. These results indicate that meningococcal infections can be prevented by single-dose administration of the quadrivalent conjugate vaccine in at-risk groups, such as soldiers, travelers, and students in dormitories. Continuous investigation is needed to determine serogroup change, including B serogroups.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Im JH, Woo H, Ha BM, et al. Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces. Vaccine. 2019. PMID: 31787413. doi:10.1016/j.vaccine.2019.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。